BGMA Hits Out At UK’s New Voluntary Pricing Scheme
Says Reference Price Calculation Is ‘Hurdle’ For Generics Industry And Risks Shortages
A fresh UK voluntary pricing scheme for branded medicines has been unveiled that includes differentiated payment mechanisms for older and newer products. However, the BGMA has hit out against aspects of the new deal that it says will provide hurdles for generics and increase the risk of drug shortages.
